Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity

2020-05-07T16:52:44+00:00 May 7th, 2020|Featured, Publications|

  • Published in Frontiers in Neurology – 2020

  • Collaborator: Ipsen

  • Authors: Jorge Jacinto, Pasquale Varriale, Emilie Pain, Andreas Lysandropoulos and Alberto Esquenazi

Botulinum toxin-A (BoNT-A) injections are first-line treatment for adult spasticity. Prior patient surveys have reported that BoNT-A treatment improves quality of life but that symptoms usually recur before the next injection.

Objective: The objective of this study was to explore, in-depth, patient perceptions of the impact of spasticity and the waning of BoNT-A therapeutic effects.